New Medical Devices.
Författaruppgift saknas
P T · news; journal article PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för uridine triacetate. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
7 hitsUridine prodrug improves memory in Tg2576 and TAPP mice and reduces pathological factors associated with Alzheimer's disease in related models.
Saydoff JA, Olariu A, Sheng J, Hu Z, Li Q, Garcia R, Pei J, Sun GY, von Borstel R.
J Alzheimers Dis · journal article · DOI 10.3233/jad-130059Use of uridine triacetate for the management of fluorouracil overdose.
McEvilly M, Popelas C, Tremmel B.
Am J Health Syst Pharm · journal article; case reports · DOI 10.2146/ajhp100434Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease.
Saydoff JA, Garcia RA, Browne SE, Liu L, Sheng J, Brenneman D, Hu Z, Cardin S, Gonzalez A, von Borstel RW, Gregorio J, Burr H, Beal MF.
Neurobiol Dis · comparative study; journal article · DOI 10.1016/j.nbd.2006.08.011Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine.
Garcia RA, Liu L, Hu Z, Gonzalez A, von Borstel RW, Saydoff JA.
Brain Res · journal article · DOI 10.1016/j.brainres.2005.10.0565-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Saif MW, von Borstel R.
Cancer Chemother Pharmacol · journal article · DOI 10.1007/s00280-005-0129-xOral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease.
Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, von Borstel RW.
Brain Res · comparative study; journal article · DOI 10.1016/j.brainres.2003.09.049